Last reviewed · How we verify
Prednisolone Acetate Ophthalmic — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Prednisolone Acetate Ophthalmic (Prednisolone Acetate Ophthalmic) — EyePoint Pharmaceuticals, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prednisolone Acetate Ophthalmic TARGET | Prednisolone Acetate Ophthalmic | EyePoint Pharmaceuticals, Inc. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prednisolone Acetate Ophthalmic CI watch — RSS
- Prednisolone Acetate Ophthalmic CI watch — Atom
- Prednisolone Acetate Ophthalmic CI watch — JSON
- Prednisolone Acetate Ophthalmic alone — RSS
Cite this brief
Drug Landscape (2026). Prednisolone Acetate Ophthalmic — Competitive Intelligence Brief. https://druglandscape.com/ci/prednisolone-acetate-ophthalmic. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab